Skip to main content

Atrial Fibrillation Clinical Trials in Oklahoma City, OK

Atrial fibrillation clinical trials, where your involvement will contribute to better health outcomes.

Enroll Now

Focus on the Hope of a Steady Rhythm

AFib Clinical Trials

Atrial fibrillation (AFib) disrupts the heart’s upper chambers, increasing stroke risk significantly, with about 1 in 7 cases attributed to AFib.

Most AFib-related strokes are ischemic, resulting from artery blockage. Anticoagulation therapy is commonly recommended for stroke prevention.

Hightower is currently conducting atrial fibrillation clinical trials in Oklahoma City, OK, investigating potential devices to reduce the risk of AFib.

*Participation in the Clinical Trial is completely free of cost and is your choice.

*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.

About Atrial Fibrillation Trials

Atrial fibrillation (AFib) is a common condition affecting millions worldwide. It disrupts your heart’s electrical signals, causing the upper chambers to quiver (fibrillate) instead of contracting normally. This irregular heartbeat can increase your risk of blood clots, stroke, heart failure, and other serious issues.

This atrial fibrillation clinical trial in Oklahoma City, OK, explores a device as a potential treatment for atrial fibrillation to see if it can effectively prevent atrial fibrillation in people with AFib. Throughout the trial, qualified healthcare professionals will provide you with comprehensive care related to the study.

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.

*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.

Get Started: What to Expect?

If you decide to participate in the atrial fibrillation clinical trials in Oklahoma City, OK, by filling out the form above, someone from the study team will contact you to determine your eligibility. The study doctors will go over the study details with you to see if you meet the eligibility criteria for the Atrial Fibrillation Clinical Trials.

You will be invited to the study location for screening if you meet the criteria. The study site will be within a 50-mile radius of your current location. The study doctors will advise you on the duration of the clinical trials for atrial fibrillation and the implications of your involvement in this research study. We invite you to ask as many questions as you like. After thoroughly explaining everything to the participants, they will be requested to sign an Informed Consent Form.

*Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.


18 years and above


Male & Female


Atrial Fibrillation

Current Status


Understanding Atrial Fibrillation (AFib)

Atrial fibrillation, often shortened to AFib, is a heart condition that affects the heart’s rhythm. Normally, your heartbeats follow a steady, organized pattern controlled by electrical signals. In AFib, these electrical signals become disorganized, causing the upper chambers of your heart (the atria) to quiver irregularly instead of beating effectively.


  • Stroke: Blood clots from AFib can travel to the brain and cause a stroke. This is a serious complication and a major concern for people with AFib.
  • Heart Failure: Over time, the irregular heartbeat from AFib can weaken the heart muscle and lead to heart failure.
  • Other Complications: AFib can also increase the risk of other heart-related problems like fatigue, shortness of breath, and chest discomfort.


  • Irregular heartbeat (feeling like your heart is fluttering, racing, or skipping beats)
  • Palpitations (feeling your heartbeat in your chest)
  • Fatigue
  • Shortness of breath
  • Lightheadedness or dizziness
  • Chest pain (although less common)

Frequently Asked Questions

What are clinical trials for atrial fibrillation?

Clinical trials for atrial fibrillation (AFib) are research studies conducted to evaluate new treatments, medications, or procedures aimed at improving outcomes for individuals with AFib.

Who can participate in clinical trials for atrial fibrillation?

Eligibility criteria vary depending on the specific trial, but generally, individuals with atrial fibrillation who meet certain health criteria may be eligible to participate. Factors such as age, medical history, and current medications may influence eligibility.

How can I learn more about a specific clinical trial for atrial fibrillation?

To learn more about a specific clinical trial for atrial fibrillation, you can contact the research team at Hightower by filling out the contact form. We are conducting a study. You can also visit our website for more information.